Phase 3 Readout~month

Phase 3 Topline: A Phase 3, Multi-Center, Randomized Study to Assess The Efficacy, Safety and Tolerability of Subreti

Indication
Retinitis Pigmentosa

Other upcoming events for OCGN

Phase 3 ReadoutPhase 3 Topline: A PHASE 1 STUDY TO ASSESS THE SAFETY AND EFFICACY OF OCU410ST FOR STARGARDT DISEASE AND PHASE 2/3 PI

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 3, Multi-Center, Randomized Study to Assess The Efficacy, Safety and Tolerability of Subreti — OCGN Phase 3 Readout | BioSniper